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Abstract
Background: Visceral leishmaniasis (VL) has been targeted by the WHO for elimination as a public health problem
(< 1 case/10,000 people/year) in the Indian sub-continent (ISC) by 2020. Bihar State in India, which accounts for the
majority of cases in the ISC, remains a major target for this elimination effort. However, there is considerable spatial,
temporal and sub-population variation in occurrence of the disease and the pathway to care, which is largely
unexplored and a threat to achieving the target.
Methods: Data from 6081 suspected VL patients who reported being clinically diagnosed during 2012–2013 across
eight districts in Bihar were analysed. Graphical comparisons and Chi-square tests were used to determine
differences in the burden of identified cases by season, district, age and sex. Log-linear regression models were
fitted to onset (of symptoms)-to-diagnosis and onset-to-treatment waiting times to estimate their associations with
age, sex, district and various socio-economic factors (SEFs). Logistic regression models were used to identify factors
associated with mortality.
Results: Comparisons of VL caseloads suggested an annual cycle peaking in January-March. A 17-fold variation in
the burden of identified cases across districts and under-representation of young children (0–5 years) relative to
age-specific populations in Bihar were observed. Women accounted for a significantly lower proportion of the
reported cases than men (41 vs 59%, P < 0.0001). Age, district of residence, house wall materials, caste, treatment
cost, travelling for diagnosis and the number of treatments for symptoms before diagnosis were identified as
correlates of waiting times. Mortality was associated with age, district of residence, onset-to-treatment waiting
time, treatment duration, cattle ownership and cost of diagnosis.
Conclusions: The distribution of VL in Bihar is highly heterogeneous, and reported caseloads and associated
mortality vary significantly across different districts, posing different challenges to the elimination campaign.
Socio-economic factors are important correlates of these differences, suggesting that elimination will require
tailoring to population and sub-population circumstances.
Keywords: Visceral leishmaniasis, Case burden, Bihar, India, Pathway to care, Onset-to-diagnosis time,
Onset-to-treatment time, Mortality, Statistical analysis
* Correspondence: sarahjervis99@gmail.com; L.Chapman.1@warwick.ac.uk
†Equal contributors
1School of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry
CV4 7AL, UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Jervis et al. Parasites & Vectors  (2017) 10:601 
DOI 10.1186/s13071-017-2530-9
Background
Visceral leishmaniasis (VL) on the Indian sub-continent
(ISC) is a disease caused by the protozoan parasite
Leishmania donovani and transmitted from human to
human by female Phlebotomus argentipes sand flies.
The symptomatic form of the disease, also known as
kala-azar (KA), is characterised by fever, weight-loss
and an enlarged liver and spleen, and has a case fatality
rate of over 95% if untreated [1]. In recent years, more
effective treatments have reduced the case fatality rate
to 10% on average [2], with studies suggesting that
proximity to a previous VL patient, bed net usage and
levels of insecticide spraying are important drivers of
VL risk [3–5]. However, the role of delays from onset-
of-symptoms to treatment has not been well quantified.
The two main strategies for control are improved case
detection and management (reductions in onset-to-
treatment time), and indoor residual spraying with
insecticide.
The ISC has historically suffered the majority of the
global burden of VL, with India, Bangladesh and Nepal
accounting for 80% of the estimated 200,000–400,000
annual global cases between 2004 and 2008 [2]. How-
ever, since 2011 there has been a significant decline in
the number of cases in the ISC [6–8]. Consequently,
reduction in the incidence of symptomatic VL, to under
1 case/10,000 people/year at sub-district level in the ISC
by 2020, is one of the WHO elimination goals. The
governments of Bangladesh, India and Nepal have set a
more ambitious goal of reaching the elimination target
by the end of 2017 [9]. The state of Bihar in northern
India is by far the most affected area within the ISC,
accounting for 80% of VL cases in India [7] and is still
far from elimination with recent estimates of 1–5 cases
per 10,000 per year at sub-district (block) level [10, 11].
Over the last 50 years, reported national and regional
VL incidence has oscillated in an approximately 15-year
cycle [12, 13], with marked declines in recent years [14].
However, there is some evidence of spatial variation in
incidence rates [11, 15], the causes of which are poorly
understood. Previous studies have found evidence of sea-
sonal variation [3, 12, 16–22], measured by incidence of
diagnosis or numbers of sand flies, but the resulting in-
ferences made on VL incidence are complicated by long
incubation periods, an uncertain proportion of asymp-
tomatically infected humans and long durations until
diagnosis [23]. There have also been few systematic
studies of seasonality across multiple areas with different
incidence rates. Variations in incidence by both age and
sex have also been inferred from many previous studies
[3, 5, 12, 21, 22, 24–28], but the majority of these are ei-
ther single-location studies or based on small numbers
of cases. Differences in incidence by location, age and
sex have often been hypothesised to be due to
differences in access to care, both in terms of individual
effects and the indirect effect of long onset-to-diagnosis
times on transmission. However, there are few studies of
large patient groups investigating drivers of onset-to-
diagnosis or treatment patterns [29].
As the VL control programme in Bihar builds towards
achieving elimination as a public health problem, and, in
the longer term, maintaining this goal and aiming for
elimination of transmission, there is a shortage of quan-
titative information on variation in case burden and
drivers of delays in diagnosis. By quantifying these fac-
tors across multiple settings, we aim to characterise key
sources of variability and inform the design of control pro-
grammes to identify and treat the final cases. Using re-
cords from 6081 suspected VL patients in eight districts in
Bihar, we highlight significant variations in the burden of
identified cases (the number of cases identified per head
of population per year) and mortality. Although incidence
of VL has been the main focus of most previous studies,
we additionally study the pathway to care for infected in-
dividuals. A large number of symptomatic cases in our
dataset, together with the multiple locations and detailed
information on socio-economic factors (SEFs) such as
housing and cattle ownership, allow us to perform a thor-
ough analysis identifying key differences in VL patients’
pathway to care and odds of survival.
Methods
Study population and VL case tracing
CARE India, a non-governmental organization, under-
took a rapid situational assessment of VL in 2013 to in-
form the operation of the kala-azar elimination
programme in Bihar. The assessment was conducted as
part of the intervention programme funded by the Bill
and Melinda Gates Foundation (BMGF) in eight (out of
a total of 38) districts of Bihar, including both high and
low endemicity districts. Only eight districts were se-
lected due to resource constraints and the need for rapid
assessment, and due to CARE India having existing in-
frastructures for conducting field research in these dis-
tricts. Due to operational feasibility, the case tracking
was limited to symptomatic VL patients only. The refer-
ence period for the assessment (the period during which
VL diagnosis took place) was January 2012 to June 2013.
The following combination of methods was followed to
meet this objective (data collection and processing are
also described elsewhere [30]):
Index case tracing and snowballing
Line lists of VL patients, whose date of diagnosis was
within the reference period, reported by the state-run
health facilities (block and district hospitals) were com-
piled. In addition, healthcare facilities belonging to the
study area, which specialized in kala-azar care, were
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contacted to obtain information on potential VL cases.
Cases obtained from these two sources were checked to
identify and remove duplicates. Attempts were made to
trace every patient whose name appeared on the
compiled list.
An interview was conducted by a trained study investi-
gator with the successfully traced patient or his/her fam-
ily members. A medical record review, for patients who
possessed any documents about diagnosis and treatment
for VL, was conducted along with the interview. Add-
itionally, patient/family members were requested to pro-
vide information on any other potential cases of VL in
the family or neighbourhood. The contact information
of such suspected patients was collected. If a patient
could not be traced to the particular address, the case
information was shared with other districts in the study,
and if the patient could still not be traced, the case was
considered untraceable.
Additionally, to increase the sensitivity of the case
finding effort, some key informants (such as community
health workers and school teachers) from the villages
mentioned in the address of potential cases were inter-
viewed to determine if they were aware of any other VL
patients or cases of prolonged fever during the reference
period, either amongst residents of the same village or
elsewhere. The contact information of any such sus-
pected cases was also collected.
Mapping and interviewing private healthcare providers
A mapping exercise was undertaken to identify all pri-
vate laboratories and pharmacists in all villages/towns of
each of the study districts. These private healthcare pro-
viders were then interviewed to ascertain if they had di-
agnosed or dispensed medications to any VL patient
during the reference period. Moreover, all qualified doc-
tors, and all unqualified practitioners with a large clien-
tele, who were captured through the provider mapping
exercise, were contacted to obtain information on any
VL patients they had seen or treated (either confirmed
or with VL-like symptoms).
The list of potential additional cases generated in this
manner was compiled and screened for duplications and
repetitions of known cases from government reported
lists, and individuals that remained on the non-duplicate
list were considered ‘suspected’ VL cases. An attempt
was made to trace each suspected case to his or her resi-
dence and interview him or her or his/her family, where
any documentary proof of diagnosis or treatment was
collected. These suspected cases were also asked about
any other cases of VL or prolonged fever that they may
have known. This iterative process continued until all
suspected cases had been interviewed.
All available details of such suspected cases were re-
corded. No attempt was made to clinically examine
suspected cases or confirm their diagnosis through
laboratory tests.
The breakdown of the sources via which patients were
identified is shown in Table 1. Fourteen percent of cases
reported by the national control programme (i.e. those
reported by the state-run health facilities) were untrace-
able. However, approximately 15% of cases identified by
the case tracing process were not recorded by the na-
tional programme, suggesting that the official figures
provide an underestimate of the true VL burden, though
much less of an underestimate than suggested by previ-
ous studies [31, 32].
VL case definition
A patient was considered to be a case of VL if he/she
met any of the following criteria:
(i) If the patient’s name and address were included in
the line list of VL patients who were diagnosed by any
government facility within the reference period and he/she
could be traced to the listed address, regardless of posses-
sion of any documents related to diagnosis or treatment.
(ii) If a potential case possessed any documents, from
a private or public facility, confirming his/her VL diag-
nosis (serological test, splenic/bone marrow biopsy)
within the study reference period.
(iii) If a potential case possessed documents demonstrat-
ing VL treatment, such as prescriptions/pharmacy slips/
drug packaging that indicated treatment with miltefosine,
sodium stibogluconate (SSG) or amphotericin B, and the
start of treatment occurred within the reference period.
Participant interview
A face-to-face interview was conducted with every eli-
gible VL patient identified using the case detection
Table 1 Sources via which VL cases were identified
Primary source via which case was identified Number Percentage
Official list from block PHC/SDH/FRU 3835 63.07
Official list from other block PHC/SDH/FRU 231 3.80
Official list from district hospital 1021 16.79
Official list from government medical college 5 0.08
Official list or patient of RMRI 7 0.12
Laboratory 31 0.51
Private hospital/doctor 126 2.07
Chemist/Pharmacist 23 0.38
Another patient 361 5.94
Key informantsa 388 6.38
Self-informed by patient 53 0.87
Total 6081 100
Abbreviations: PHC Primary Health Centre, SDH Sub-Divisional Hospital,
FRU First Referral Unit, RMRI Rajendra Memorial Research Institute, Patna, Bihar
aKey informants: Accredited Social Health Activists (ASHAs), villagers, friends,
relatives, school teachers
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methodology. If a patient died in the interim, the inter-
view was conducted with the next-of-kin. Data were col-
lected on, among other things, socio-demographic
characteristics (age, sex, district), date of onset of symp-
toms, place and date of diagnosis, pre- and post-
diagnosis treatment history, and type and duration of
drug treatment. Whenever available, information on
treatment and diagnosis history was recorded from med-
ical documents. Data were entered using the Census and
Survey Processing System CSPro 5.0 and assessed for lo-
gical inconsistencies and to detect and remove duplicate
entries.
Statistical analyses
Our analyses were conducted using data from the retro-
spective clinical case finding and patient interviews de-
scribed above. This dataset consists of information on
6081 suspected VL cases. A flowchart showing the inclu-
sion criteria for VL cases for the statistical analyses is
presented in Fig. 1.
Burden of identified cases: Seasonal and district-specific
variation and age distribution
Unlike some previously reported studies [3, 4] all indi-
viduals in the CARE dataset were symptomatic patients.
The lack of a control group of disease-free individuals
meant that analyses to determine the association of
SEFs, such as housing or cattle ownership, with VL risk
were not possible. To compare the burdens of identified
VL cases in different districts, the expected proportion
of VL in each district was computed as being equal to
the population proportion (of the eight districts com-
bined), and a Chi-square test was used to judge the col-
lective significance of differences between observed and
expected case burdens. Using 2011 census populations
by district [33], the sex distribution of cases was ana-
lysed following a similar procedure, and the district age
distributions of cases were compared. Monthly numbers
per district of onsets and diagnoses in 2011–2013 were
computed and plotted to examine seasonal variation.
Variation in the pathway to care and mortality
The data included information on house construction
and size, wall, floor and ceiling materials, cattle owner-
ship and financial contributions to diagnostic tests and
treatment. All of these could be viewed as surrogate in-
dicators of economic status, and many could influence
the pathway to care. Thus, the effects of variations in
housing, cattle ownership and paid-for vs free services
on onset-to-diagnosis (OD) and onset-to-treatment (OT)
waiting times were analysed together with age, sex and
district. As both waiting times have right-skewed
Fig. 1 Flowchart for the inclusion of VL cases in statistical analyses. Abbreviations: OD, onset-to-diagnosis; OT, onset-to-treatment;
NB, negative binomial
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distributions with variances much larger than their
means (variance/mean = 47.06 days and 38.46 days for
the OD and OT times, respectively), negative binomial
regression models with exponential link function were
used to analyse them. Due to the finite sampling period,
there was a bias towards elongated waiting times at the
start of the sampling period and shorter waiting times at
the end. Therefore we restricted the analysis to the cen-
tral portion of the data time-period (details in Results).
First, single-variable models were fitted to eliminate the
least significant relationships, then multivariable models
for comparison purposes. Starting with all variables
judged significant in single-variable models, factors were
accepted or rejected using the likelihood ratio test
(LRT). Using a logistic regression model, with a similar
selection procedure, we investigated the effects of the
same set of factors together with OD and OT waiting
times on patients’ risk of death. Although no informa-
tion as to causes of individuals’ deaths was available,
death rates appeared to be both much higher and differ-
ently distributed over age and sex amongst patients than
in the general Bihar population, such that it seems likely
the excess mortality was VL related. To increase under-
standing of factors influencing overall mortality amongst
VL patients, we consequently analysed the risk of dying
from any cause during the study period. All regression
analyses were performed using Stata 14 [34].
Results
A total of 6081 suspected VL cases from 131 blocks in
eight districts of Bihar were identified in the VL situational
assessment. One hundred and fifty-one cases were re-
corded as having post-kala-azar dermal leishmaniasis
(PKDL) and were excluded from all analyses due to uncer-
tainty about whether their illness and treatment data re-
ferred to VL or PKDL. Among the 5930 cases remaining,
59% were male, and 41% female; median age was 20, vary-
ing from 16 to 30 between districts (see Additional file 1:
Table S1 and Additional file 2: Table S2).
Burden of identified cases
Monthly counts of diagnoses in January 2012 - June
2013 by district are displayed in Fig. 2a. The monthly
numbers of cases by onset for each district have been
plotted from the patients’ self-reported onset dates in
Fig. 2b. Since inclusion in the study was based on the
date of diagnosis being between 1st January 2012 and
30th June 2013, there was an inherent bias towards lon-
ger OD times amongst cases with onset prior to 2012,
and towards shorter OD times amongst cases with onset
after June 2013 (see Additional file 3: Figure S1). Hence,
these cases were excluded from the analysis. Patterns of
monthly case numbers in most districts in 2012–2013
suggest an annual cycle peaking early in the year
(Fig. 2b), though differences between the 2 years’ and
eight districts’ maximum and minimum values make it
difficult to establish a consistent seasonal pattern.
For comparison of identified case burden between
districts, the total population of the blocks in each
district with at least one case in January 2012 - June
2013 [35], defined by date of onset, was used to com-
pute the case burden in 2012–2013. Displayed in
Table 2 in decreasing order of number of cases, the
district burdens of identified cases varied 17-fold from
about 1/2000/year to 3/100,000/year. This variation
was particularly marked in Saharsa with cases per head al-
most 3-fold larger than any other district, and Patna and
West Champaran, where cases per head were 3-fold lower
than any other district. The Chi-square test statistic
comparing observed and expected numbers was very large
(χ2 = 4143.7, df = 7, P < 0.0001), indicating that relative
per-district reported numbers of cases are very different to
those expected from the district populations alone. To
look for relationships between waiting times and rela-
tive case counts, yearly district case burdens in January
2012 - June 2013 (computed as annual num-
ber of cases/10,000 of the population) were plotted
against median OD and OT times in Fig. 3. Although
there was no apparent positive or negative relationship,
this does not necessarily mean that reducing waiting
times does not lead to significant reductions in case
burdens, as there will be a lag before the impact on the
case burden is observed. Furthermore, districts that
have high case burdens may have shorter OD and OT
times due to greater awareness and surveillance of VL,
and vice versa for districts with low case burdens.
The maps of Bihar in Fig. 4a and b show the total
numbers of identified VL cases with onset between
January 2012 and June 2013 at the district level and
block level, respectively. Equivalent maps for the burden
of identified cases at district and block level are provided
in Additional file 4: Figure S2. It is clear from these
maps that there is considerable spatial heterogeneity in
the occurrence of VL. The block-level maps reveal that
there is large variation in the identified burden within
high-burden districts, with cases per head per year ran-
ging from 1.69/10,000 to over 9/10,000 in blocks in
Saharsa and 0.04–6.17/10,000 in East Champaran, with a
small number of blocks contributing the majority of the
overall burden in these districts. While there appears to
be some spatial correlation in reported caseloads at the
block level (Additional file 4: Figure S2), there are also
blocks with large numbers of identified cases neighbour-
ing blocks with very few cases.
Age and sex distributions
As illustrated in Fig. 5a, the age distribution of patients
did not vary significantly between districts, despite large
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Fig. 2 Number of VL diagnoses per month and district by date of diagnosis (a) and date of onset of symptoms (b). Data were collected on cases
diagnosed between January 2012 and June 2013, and therefore incidence outside these periods is marked by a grey box
Table 2 Comparison of burden of identified VL cases in eight districts of Bihar, January 2012 - June 2013
District Total population
of affected blocksa
Number of VL
cases identified
Number of VL cases
with onset between
Jan 2012 & Jun 2013
Burden of identified
cases (cases/10,000/year)
Chi-square
statistic
Saharsa 1,900,661 1639 1447 5.075 3012.16
E. Champaran 5,099,371 1383 1214 1.587 38.45
Samastipur 4,261,566 925 862 1.348 0.189
Gopalganj 2,562,012 799 666 1.733 47.28
Begusarai 2,939,764 487 459 1.041 27.49
Khagaria 1,666,886 393 344 1.376 0.418
Patna 5,772,300 289 259 0.299 690.75
W. Champaran 2,776,365 166 128 0.307 326.95
Total 26,978,925 6081 5379 1.329 4143.7*
*P-value < 0.0001, df = 7, indicating statistically significant difference between identified case burdens and expected case burdens based on district populations
aBlock populations from 2011 Indian Census [35]
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variability in case counts. For most districts, the propor-
tion of overall cases increases from age 0 to a maximum
in 10–14 year-olds, then decreases quickly up to around
age 20, and after that decreases more slowly with age.
Most districts showed a notable lack of juvenile cases,
compared with the corresponding population age distri-
bution. While the cumulative age-distribution of the
eight districts shows a general decrease with age, the
cases-per-head was only 10.32/100,000 among 0–5 year-
olds increasing to 27.81/100,000 in the 10–14 age group,
before dipping and then increasing to 26.28/100,000 in
the 60–64 age group (see Table 3). A Chi-square test com-
paring male and female patient numbers of 3501:2422
with population proportions of 14,737,088:13,445,449 gave
a χ2 statistic of 109 (df = 1, P < 0.0001), suggesting that
men have significantly higher chances of being diagnosed
with symptomatic VL than women. Comparing the bur-
den of identified cases by age group for males and females
(see Fig. 5b) showed that the under-representation of VL
in children was common to both sexes and that the lower
rates in females were due to the numbers of reported
cases in adult women being reduced relative to men, par-
ticularly in older age groups, rates in the 0–14 age range
being nearly identical.
Variation in the pathway to care
The district-specific distributions of OD lag, OT lag and
treatment durations are illustrated in Fig. 6, and their
summary statistics are given in Table 4. Very little differ-
ence in treatment duration was observed, with patients
in all districts undergoing a median of 4 weeks treat-
ment. OD and OT time varied more, from 16.5 and
17 days in Begusarai (IQR 7–32 and 8–31) to 55 and 45
days (IQR 30.5–80 and 25–90) in West Champaran. Per-
haps counterintuitively, patients appeared to wait slightly
longer on average for diagnosis than for treatment (me-
dian 31 vs 30 days); however, this can be attributed to
the delay between clinical examination and diagnostic
testing for VL and official confirmation of the VL diag-
nosis. Treatment for VL, as a high-mortality-rate disease,
a
b
Fig. 3 Annual burden of identified cases by district plotted against median onset-to-diagnosis (OD) time (a) and median onset-to-treatment (OT)
time (b)
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is likely to have begun shortly after the patient presented
with symptoms, but the official diagnosis may not have
been recorded until 1 or 2 days later. Additionally, the
reliance on self-reported onset dates and illness dura-
tions is likely to have introduced some uncertainty into
the reported waiting times.
Several factors were associated with variation in OD
and OT waiting times. The magnitudes of the effects
of age, sex, district, housing and diagnosis/treatment
facility are displayed in Additional file 5: Table S3 as
regression model rate ratios. Waiting times were
estimated to increase by 0.4% and 0.5%, respectively,
for every year increase in age. OD time was estimated
to be up to 3.2 times longer and OT time 2.9 times
longer in other districts relative to Begusarai, the
district with the shortest average waiting times. Living
in a mud-walled house was found to be associated
with an 11–12% reduction and stone-walled house
with a 6% increase in both waiting times relative to
houses with other wall types. Cattle ownership was
associated with a 6% increase in OD time while hav-
ing a house with more than two rooms was estimated
to confer a 19–23% increase in waiting times. Paying
for diagnosis and being diagnosed at a private centre
had near identical effects, with both waiting times
appearing to be shorter for individuals choosing to
use free services. Being lower-caste was also associ-
ated with a 10–11% reduction in waiting times.
Patients’ travelling outside their block of residence
was estimated to confer a 15–18% increase in their
a
b
Fig. 4 Maps of Bihar showing total numbers of identified VL cases in the eight study districts between January 2012 and June 2013 at district
level (a) and block level (b)
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waiting times, while the effect of travelling outside
their home district appeared to be smaller but still
significant at 12–13%. Relative OD and OT waiting
times appeared reduced for 1 or 2 pre-diagnosis treat-
ments (PDTs) and significantly increased for 4 PDTs,
with rate ratios rising from 0.53–0.66 for one PDT to
1.21–1.51 for four PDTs. Neither waiting time showed
any significant association with gender, house type,
roofing or flooring materials, or public vs private
treatment.
In the multivariable regressions, house size, cattle
ownership, diagnosis cost and public vs private diagnosis
were eliminated from both waiting-time models. Treat-
ment cost and same-block diagnosis were not signifi-
cantly associated with OD, and caste was not
significantly associated with OT in the multivariable
models (see Table 5 for the optimised models and their
covariates’ relative risks and P-values). In combination
with other factors, the effect of paying for treatment ap-
peared to be reversed, moving from an increase of 6–9%
to a reduction of 8% (95% CI 3–13%). Waiting times
were still estimated to increase with the number of pre-
diagnosis treatments; considerably for OD, with rate ra-
tios from 1.64 (95% CI: 1.22–2.21) for 1 PDT to 3.70
(95% CI: 2.73–5.00) for 4, less markedly for OT, from
1.04 (95% CI: 0.82–1.31) for 2 PDTs to 1.71 (95% CI:
1.35–2.17) for 4. The measures of association for age,
district, wall material, caste and travelling for diagnosis
remained similar to those observed in the univariate
model analyses. When interactions between variables
were added to the model, no significant improvement in
goodness-of-fit was observed.
a
b
Fig. 5 Age distribution of cases. The proportion of cases in 5-year age groups by district (a) and proportions of male and female cases in 5-year
age groups across all eight districts (b)
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Factors influencing mortality rates
Analysis of age- and sex-specific death rates among VL
patients with onset of symptoms in 2012 revealed that
for 0–14 year-olds mortality was higher among females
than males, with the pattern reversed in adults (see
Table 6). Even though all patients within the study were
assumed to have received treatment, death rates were
still much higher in all age groups and both sexes
amongst patients than the general Bihar population
(apart from women over the age of 60) in 2012 [36], and
showed different patterns with age and sex more closely
resembling the age-sex distribution of VL cases. This
suggests that VL patients had an elevated risk of dying,
as noticed in previous studies [37], and factors under-
lying this were thus worthy of investigation.
Comparison of P-values and log-likelihoods for univar-
iate logistic models indicated that sex, all housing fac-
tors, free vs paid-for treatment, public vs private
facilities, caste, the number of pre-diagnosis treatments,
and diagnosis within vs without block- and district-of-
residence had no significant association with risk of
death. By backwards selection starting from a model in-
corporating age, district, waiting times, cattle ownership
and free vs paid-for diagnostic test, death risk was subse-
quently shown to have no significant association with
OD time (see Table 7 for the optimised model and the
covariates’ relative risks and P-values). The greatest risk-
reducer appeared to be cattle ownership, conferring a
39.4% reduction, and free diagnosis was associated with
a more than two-fold increase in mortality risk, with an
odds ratio of 2.19, although the confidence intervals
(CIs) of both odds ratios were quite wide at 0.44–0.85
and 1.49–3.21 respectively. Each additional year of age
was associated with a 3% increase in risk (95% CI: 2.5–
4.0%) and each extra day waiting for treatment conferred
a small but significant 0.6% increase (95% CI: 0.2–0.9%).
Although there are possible confounding factors, death
risk was estimated to decrease by 9% per day of treat-
ment (95% CI: 7–11%).
Forward selection exploring models with pairwise in-
teractions between district and other factors found no
significant variation in associations between districts.
Similarly, models incorporating interactions between
multiple housing-material factors did not fit significantly
better than those without interactions.
Discussion
This study is one of few to assess variation in VL case
burden in Bihar and the first to examine the spatial dif-
ferences and effects of socio-economic factors (SEFs) on
VL mortality rates, diagnosis and treatment in the ISC,
highlighting important variability in the pathway to care.
Burden of identified cases: Spatial, seasonal, sex- and
age-specific variations
Although calculation of district-specific incidences was
not possible due to insufficient knowledge of the popula-
tion- and person-time- at-risk, comparing case counts of
some districts with their respective populations shows
that there are significant differences in their burdens of
identified cases. The districts with the highest and lowest
numbers of reported cases were Saharsa and West
Champaran respectively, despite the latter having the
larger population. There is also strong spatial heterogen-
eity in the numbers and burdens of identified cases at
the block level, with greater variation in block burdens
than district burdens.
At state-level there has been a significant decline in
the number of reported VL cases in Bihar since 2011
(from 25,222 cases in 2011 to 4773 cases in 2016) [7],
and in all districts in this study apart from West
Champaran the total number of identified cases de-
creased between January-June 2012 and January-June
2013 (Fig. 2b). There are various factors that may have
contributed to this decrease. One is greater availability
and awareness of free diagnosis and treatment in gov-
ernment health centres [38] and shorter times to treat-
ment (cf. Table 4 with Table 1 in [39]), which may have
led to significant reductions in transmission by shorten-
ing the periods for which VL cases are infectious.
Another is reported increased coverage of indoor
residual insecticide spraying (IRS) [28, 40], which may
have reduced transmission by reducing sand fly dens-
ities. However, whether IRS coverage in the eight study
Table 3 Identified VL case burden by age group
Age group (years) Populationa No. of cases Ratio (per 100,000)
0–4 3,508,474 362 10.32
5–9 4,123,615 934 22.65
10–14 3,776,045 1050 27.81
15–19 2,516,831 554 22.01
20–24 2,186,709 400 18.29
25–29 2,101,279 431 20.51
30–34 1,949,196 452 23.19
35–39 1,766,119 385 21.80
40–44 1,396,862 327 23.41
45–49 1,156,831 263 22.73
50–54 901,989 228 25.28
55–59 763,541 160 20.95
60–64 818,092 215 26.28
65–69 547,191 109 19.92
70–74 358,440 30 8.37
75–79 140,327 10 7.13
80+ 170,996 13 7.60
aPopulation age distribution for the 8 study districts, taken from [33]
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Fig. 6 Distributions of onset-to-diagnosis (OD) (a) and onset-to-treatment (OT) (b) waiting times by district
Table 4 District-specific summary statistics for onset-to-diagnosis times, onset-to-treatment times and mortality used in regression
analyses
Onset-to-diagnosis time (days) (n = 4234) Onset-to-treatment time (days) (n = 4145) Mortality (n = 4628)
Mean Median IQR Mean Median IQR Number Died % died % deaths
Saharsa 36.58 31 19–44 34.17 30 20–40 1181 43 3.64 26.06
E. Champaran 51.00 42 28–63 51.22 42 29–61 1136 45 3.96 27.27
Samastipur 37.67 30 19–46 36.52 30 20–45 743 21 2.83 12.73
Gopalganj 47.52 35 18–61 46.70 34 17–60 620 26 4.19 15.76
Begusarai 22.50 16.5 7–32 21.99 17 7–31 356 14 3.93 8.48
Khagaria 37.18 30 20–43 34.43 30 20–38 294 6 2.04 3.64
Patna 48.95 38 27–62 44.54 35 23–59 223 9 4.04 5.45
W. Champaran 59.22 55 30.5–80 59.33 45 25–90 75 1 1.33 0.61
All districts 41.95 31 20–56 40.85 30 20–53 4628 165 3.57 100
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districts increased before 2012 is uncertain, and there is
evidence of sub-standard IRS implementation and wide-
spread sand fly resistance to DDT (dichlorodiphenyltri-
chloroethane, the insecticide used at the time) in Bihar
[41–43]. Given the long-term cycles in reported case
numbers [12, 13], it is also possible that much of the de-
crease is due to long-lasting immunity having built up in
populations affected during the previous epidemic in the
late 2000s, such that the pool of susceptible individuals
who can become infected and develop VL has been
depleted [44].
The annual cycle observed in 2012–2013 monthly
onsets and, to a lesser extent, in monthly diagnosis num-
bers, is almost certainly attributable to seasonal variation
Table 5 Rate ratios (and 95% confidence intervals) for VL patients’ onset-to-diagnosis (OD) and onset-to-treatment (OT) times for
different factors, from multivariable negative-binomial regression models; Bihar, 2012–2013
Variable Onset-to-diagnosis time (n = 4234) Onset-to-treatment time (n = 4145)
No. of patients Rate ratio (95% CI) P-value No. of patients Rate ratio (95% CI) P-value
Age Each 1-year increase 4234 1.003 (1.002–1.004) < 10−4 4145 1.003 (1.002–1.004) < 10−4
Districta Saharsa 956 1.99 (1.82–2.18) < 10−4 927 1.94 (1.77–2.12) < 10−4
E. Champaran 1108 2.26 (2.07–2.47) < 10−4 1102 2.33 (2.14–2.54) < 10−4
Samastipur 710 2.17 (1.97–2.39) < 10−4 682 2.16 (1.97–2.38) < 10−4
Gopalganj 572 2.22 (2.01–2.45) < 10−4 567 2.28 (2.07–2.51) < 10−4
Begusarai 326 – – 318 – –
Khagaria 291 1.61 (1.44–1.80) < 10−4 277 1.56 (1.40–1.74) < 10–4
Patna 195 1.85 (1.63–2.10) < 10−4 194 1.76 (1.55–1.99) < 10–4
W. Champaran 76 2.75 (2.30–3.27) < 10−4 78 2.74 (2.29–3.28) < 10–4
Wallb Grass + straw 2034 1.05 (0.97–1.12) 0.220 1994 1.07 (0.99–1.14) 0.077
Mud 478 – – 469 – –
Mud, stone 812 1.10 (1.02–1.20) 0.014 787 1.14 (1.06–1.23) 0.001
Concrete 910 1.004 (0.93–1.09) 0.916 895 1.01 (0.94–1.09) 0.752
No. of pre-diagnosis
treatments
0 23 – – 39 – –
1 1585 1.64 (1.22–2.21) < 10−4 1548 0.78 (0.61–0.98) 0.032
2 1452 2.18 (1.62–2.94) < 10−4 1407 1.04 (0.82–1.31) 0.758
3 748 2.99 (2.22–4.03) < 10−4 736 1.37 (1.09–1.74) 0.008
4 426 3.70 (2.73–5.00) < 10−4 415 1.71 (1.35–2.17) < 10−4
Lower caste No 2943 – – – – –
Yes 1291 0.95 (0.91–0.99) 0.029 –
Treatment cost Free – – – 3379 – –
Paid – – – 766 0.92 (0.87–0.97) 0.003
Same-district diagnosis No 332 – – 321 – –
Yes 3902 0.92 (0.85–0.99) 0.037 3824 0.90 (0.83–0.98) 0.011
Same-block diagnosis No – – – 1850 – –
Yes – – – 2295 0.95 (0.905–0.995) 0.032
aBaseline is Begusarai as district with shortest average OD and OT waiting times
bBaseline is mud-walled housing as housing type with shortest average OT waiting time
Table 6 Comparison of age-specific death rates in VL patients and in Bihar population
Age
group
VL patients (2012) Deaths (2012) Deaths per 1000 VL cases per year Deaths per 1000 general population per year (2012)a
Male Female Total Male Female Total Male Female Total Male Female Total
0–4 84 116 200 2 8 10 23.81 68.97 50.00 11.2 11.8 11.5
5–14 649 556 1205 5 18 23 7.70 32.37 19.09 0.9 0.8 0.9
15–59 1234 777 2011 60 32 92 48.62 41.18 45.75 3.2 2.6 2.9
60+ 174 51 225 26 3 29 149.43 58.82 128.89 42.9 49.0 45.7
aFrom [36]
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in sand fly populations. The majority of previous
studies of seasonal variation in sand fly numbers
found the vector density to be positively correlated
with temperature and negatively correlated with rain-
fall [16–19]. Peak populations were recorded in sum-
mer and after the end of the rainy season, although
with variations (March-April and November [16],
May-July and October-November [17], March-May
[18], and June-July and November [19]). The summer
(March-May) peak appears to coincide with that seen
both in the monthly onsets in this study and in other
studies examining VL seasonality, which found cases
to peak in March-April [20, 22]. This is unexpected;
given an infected-symptomatic sojourn time of 2–
5 months [3, 15, 23, 45], one would expect cases to
peak later in the year than sand fly density, and in-
deed some studies have observed highest numbers of
VL cases in July-September or April-June and lowest
numbers in January-March [3, 12, 18, 21]. However,
the peak in cases in March - April fits with the peak
in sand fly abundance after the rainy season (Octo-
ber-November) in the previous year. One possible ex-
planation for the lack of a second case peak after the
summer sand fly peak could be that the proportion
of infective sand flies only peaks once, late in the
year [46]. Variation in the timing and appearance of
the case peak is likely to be due to the considerable
variation in the incubation period for disease (since
longer incubation periods dampen the seasonality in
the number of cases from that in the sand fly
abundance [47]). However, the previous studies sug-
gesting a later peak incidence than our analyses had
some weaknesses as ascertainers of seasonality. The
studies by Bern and Perry et al. [3, 21] were both
cross-sectional studies with relatively low numbers of
actual symptomatic VL patients, and the historical
case counts used by Bora [12] are likely to be num-
bers of diagnoses rather than onsets, which could
easily explain the relative delay in peak cases via the
added OD waiting times. Although both onset and
diagnosis numbers in our data show an annual cycle,
the oscillation is much less clear in the monthly
diagnosis numbers. This adds uncertainty to the sea-
sonality reported by Bora [12] and suggests that
added variation from factors such as waiting times
can easily distort or cloud the results of diagnostic
tests as a representation of temporal VL distribution.
Thus, future studies examining symptomatic VL epi-
demiology might be better using patients’ records of
their disease progression, as used here, rather than
clinical test results, even accounting for the greater
measurement errors associated with self-reported
data. To overcome the uncertainty about the rela-
tionship between seasonally varying sand fly and case
numbers, the two need to be measured simultan-
eously and a better understanding of asymptomatic
sojourn times is needed.
As illustrated in Fig. 5a and Table 3, young children
are noticeably less affected by VL relative to the age dis-
tribution of the general population. Although this is in
Table 7 Odds ratios (and 95% confidence intervals) for VL patients’ risk of death for different factors, from multivariable logistic
regression model; Bihar, 2012–2013 (n = 4628)
Variable No. of patients Odds ratio 95% CI P-value
Total Dead
Age Each 1-year increase 4628 165 1.03 1.025–1.04 < 10−4
District Saharsa 1181 43 2.65 1.07–6.57 0.036
E. Champaran 1136 45 2.60 1.04–6.48 0.040
Samastipur 743 21 1.58 0.60–4.15 0.357
Gopalganj 620 26 2.96 1.11–7.85 0.029
Begusarai 356 14 3.22 1.16–8.91 0.025
Khagaria 294 6 – – –
Patna 223 9 1.85 0.62–5.53 0.272
W. Champaran 75 1 0.71 0.08–6.18 0.754
Onset-to-treatment time Each 1-day increase 4628 165 1.006 1.002–1.009 0.002
Treatment duration Each 1-day increase 0.91 0.89–0.93 < 10−4
Cattle owner No 1767 79 – – –
Yes 2861 86 0.61 0.44–0.85 0.004
Paid for test Paid 1980 53 – – –
Free 2648 112 2.19 1.49–3.21 < 10−4
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contrast to the study by Perry et al. [21] which estimated
the 0–10 age group to be at highest risk and the 11–20
age group at lowest risk of VL, Perry et al. [21] only in-
cluded 45 symptomatic VL cases and a reduced inci-
dence of VL in young children has been observed in the
majority of previous studies [3, 5, 12, 22, 24, 27, 28]. If
the apparently low burden of cases in under-fives does
reflect the actual underlying age distribution of disease,
a possible explanation is variation in sand fly exposure:
via different patterns of daytime movement or prioritisa-
tion of bed nets, young children have lower levels of VL
infection because they are less frequently bitten by sand
flies. Another hypothesis for under-representation is
under-reporting of symptomatic VL in children: in re-
gions where there are many infant deaths due to fever,
many fatal VL cases in infants could have been passed
over when collecting our dataset. This is suggested by
Bihar population surveys reviewed by Bora [12], where
the 1989 number of cases in the 0–9 age group is 8.6%
higher than that in 1979; given that the population-wide
case counts are similar in the 2 years, it is possible that
an apparent increase in children is due to a reduction in
under-reporting rather than an actual change in age-
specific levels due to the long-term dynamics of the dis-
ease. It is also possible that there is little variation by age
in actual biting and infection rates, but children have a
lower probability of an asymptomatic infection develop-
ing into clinical VL, so are consequently rarer in the
symptomatic population.
The hypotheses of lower exposure of susceptible indi-
viduals or lower probability of infected individuals becom-
ing symptomatic could also account for the apparent
shortfall in VL cases among women relative to men, also
reported by previous studies [3, 5, 12, 21, 22, 24–27, 48].
Another possible explanation is under-reporting of female
cases due to women having, on average, poorer access to
appropriate healthcare. This hypothesis is supported by
Alvar et al. [49], where 60–80% of health facility patients
were male while sex ratios were almost equal in
population-based studies. This theory could also explain
why only adult women appear to have reduced risk: before
the age of 15, say, males and females are equally likely for
their parents/guardians to take them to a doctor when un-
well, while adult women are less able than men to travel
to healthcare facilities. Given that our analyses of fac-
tors affecting waiting times for diagnosis and treatment
(discussed in more detail below) found no significant
difference between sexes, it would seem probable that
reduced access to healthcare for women is more likely
to have manifest as a lack of, rather than a delay in,
diagnosis and treatment for some symptomatically
infected women. The apparent widening of the gap
between the numbers of identified cases in men and in
women with age in our data is strikingly similar to that
observed in a study of 8749 VL patients from the
Vaishali district of Bihar [22], and emphasises the need
for further investigation of the factors affecting
reported numbers of male and female cases.
Significant differences in the pathway to care
In our analyses of waiting times, we found significant
differences between districts even after the inclusion of
many SEFs one might expect to account for such vari-
ation. Given that several SEFs found to be significant in
univariate regression models were subsequently excluded
from multivariate models, this could be because an indi-
vidual’s district is a more informative (summary) meas-
ure of their effective socio-economic status than any
available single SEF and as such, the spatial association
might be replaceable by the right combination of SEFs.
Alternatively, the observed association might be attribut-
able to unmeasured variation in health provision be-
tween districts; this could include healthcare staffing
levels and VL awareness, as well as documented statis-
tics such as relative availability of public health centres.
Out of the other factors judged to have significant ef-
fects, having more PDTs or having to travel outside one’s
residential area were unsurprisingly estimated to in-
crease both waiting times. Somewhat unexpectedly, pay-
ing for treatment appeared to decrease OT waiting
times only when in combination with other variables,
and lower-caste individuals were estimated to have
shorter diagnosis and treatment waiting times on aver-
age. The apparent reduction in waiting times for lower-
caste individuals is likely also due to a difference in
awareness; as VL is a disease associated with poverty,
clinical practitioners might be more likely to VL-test and
medicate a lower-caste patient with a fever.
Mortality
Another important issue for minimising the effects of
VL as a public health problem is the reduction of mor-
tality related to the disease. To develop a strategy for
this, it is necessary to understand which factors signifi-
cantly influence mortality among patients. Comparing
the effects of numerous factors on an individual’s prob-
ability of death using logistic regression models, some-
what surprisingly no significant difference was found
between sexes or different housing types and materials.
The increase in mortality with age was unsurprising, as
was the small but significant increase with waiting-time
to treatment. The associations between increased treat-
ment duration and cattle ownership and lower mortality
are more difficult to interpret: the former might be
biased by some individuals only receiving longer treat-
ments because they survived the pre- or early-treatment
stage, while cattle ownership might be directly protective
via better nutrition but alternatively could just be a
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marker of higher average socio-economic status. The
lower mortality among patients paying for diagnosis
could be wealth-related: higher-income individuals
might be more likely to pay for care, or facilities provid-
ing free diagnosis tests might be more accessible in
poorer areas, with differences in mortality thus attribut-
able to wealth-associated differences in average baseline
health. Due probably to the low numbers of VL patients
and thus even lower number of patient deaths observ-
able from case-control studies, there appear to be very
few previous studies examining factors affecting mortal-
ity rates amongst VL patients. Barnett et al. [25] and
Huda et al. [50] both reported differences in male and
female mortality rates, whereas sex was not found to sig-
nificantly affect death risk in our regression analyses.
However, these two studies suggested opposing results -
33 vs 75% of deaths among males - and were based on
very low numbers of deaths–8 and 9, respectively. Simi-
larly to our analyses, a recent study using the same data
source, by Das et al. [30] found cattle ownership and
shorter onset-to-diagnosis waiting times to be associated
with a reduced death risk and age and private treatment
associated with an increased risk, but gender to have little
effect. Although the results in Das et al. [30] also sug-
gested that house type and caste affected mortality while
these were eliminated from our preferred model, this is
likely due to a difference in methods; Das et al. measured
variations in death risk over time using Cox proportional
hazard models while our analyses were of the total haz-
ard of dying. Consequently, it could be that caste and
house type have a significant effect on time-dependent
risk of death but not the overall risk. Alternatively, the
inclusion of district in our regression analyses might
have accounted for variations in mortality attributed to
housing or caste in [30].
Our analyses did have several limitations. The lack of
information on disease-free individuals prevented any
investigation of the effects of SEFs on VL incidence
across Bihar. The use of retrospective questionnaires for
data collection meanwhile meant that records of both
key dates along the pathway to care and some SEFs were
incomplete and sometimes contradictory, while the re-
cords of deaths within the study did not differentiate be-
tween deaths caused by VL and those from other causes.
Nevertheless, we were able to gain valuable insight into
the effects of housing, cattle and location on VL diagno-
sis and treatment as well as variations in the distribution
of the disease itself.
Conclusions
We conclude that in various VL-endemic districts of
Bihar there remain challenges in the elimination of VL
and that there is considerable variation between regions
in the pathway to care. For long-term control, more
attention needs to be focused on districts with a high
case burden, and efforts should be made in all regions to
reduce waiting times for diagnosis and treatment, either
by increasing provision or awareness, and to improve
healthcare access for women.
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